Yin DT, et al. - Robotic thymectomy has been suggested a feasible and safe approach for myasthenia gravis (MG). Few investigations have revealed the independent effect of robotic thymectomy without the confounding impact of immunosuppressive (IM) therapy. In this current investigation, it was demonstrated that satisfactory long-term outcome may be provided by mono-therapy of robotic thymectomy for part of MG patients. Of utmost importance are precision selection and individualized therapy.